CURVEBEAM AI ORD
CurveBeam AI wins Chinese approval for $10m WEGO investment
CurveBeam AI (ASX: CVB) wins Chinese regulatory approval for a $10m WEGO Orthopaedics strategic investment, initial $4m tranche, 10-year exclusive China deal.
Why Investors Can’t Miss Spark Plus Australian Equities Day 2025
Discover Australia’s Next Wave of Growth The Spark Plus Australian Equities Day 2025 is more than just another investor showcase—it’s your gateway to the next generation of ASX growth stories. Across 18 power-packed presentations, this event brings together some of Australia’s most ambitious companies, each sitting at the cutting edge of their sectors and driving […]
ASX Investment Opportunities on Show in Singapore During Grand Prix
All roads will lead to Singapore in early October with the important Spark Plus Aussie Equities Day investment show being staged in the lead-up to the local grand prix motoring event. The 2025 Spark Plus Aussie Equities Day is the 4th installment of their flagship event which aims to introduce a range of Australian companies to […]
CurveBeam AI achieves increased purchase orders for first quarter of FY24
Medical imaging equipment provider CurveBeam AI (ASX: CVB) has achieved a key metric of increased purchase order sales for the first quarter of the 2024 financial year. The company received four purchase orders for its flagship HiRise scanner device in the period ending 30 September, representing a 100% increase on the same time last year […]